These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 10742386

  • 21. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
    Zhong RK, Lane TA, Ball ED.
    Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
    [Abstract] [Full Text] [Related]

  • 22. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W, Xing P, Wei X, Wang T, Yang D, Li M.
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [Abstract] [Full Text] [Related]

  • 23. Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.
    Orsini E, Calabrese E, Maggio R, Pasquale A, Nanni M, Trasarti S, Tafuri A, Guarini A, Foa R.
    Leuk Res; 2006 Jul; 30(7):785-94. PubMed ID: 16527350
    [Abstract] [Full Text] [Related]

  • 24. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells.
    Cignetti A, Bryant E, Allione B, Vitale A, Foa R, Cheever MA.
    Blood; 1999 Sep 15; 94(6):2048-55. PubMed ID: 10477734
    [Abstract] [Full Text] [Related]

  • 25. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
    Sheng LX, Xie XB, Qiu GQ, Gu WY, Wang ZL, Wu HQ.
    Ai Zheng; 2005 Nov 15; 24(11):1338-44. PubMed ID: 16552959
    [Abstract] [Full Text] [Related]

  • 26. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH, Kang HK, Park JS, Kim SK, Pham TN, Zhu XW, Cho D, Nam JH, Chung IJ, Kim YJ, Rhee JH, Kim HJ, Lee JJ.
    J Clin Apher; 2006 Dec 15; 21(4):233-40. PubMed ID: 17120232
    [Abstract] [Full Text] [Related]

  • 27. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
    Liepert A, Grabrucker C, Kremser A, Dreyssig J, Ansprenger C, Freudenreich M, Kroell T, Reibke R, Tischer J, Schweiger C, Schmid C, Kolb HJ, Schmetzer H.
    Cell Immunol; 2010 Dec 15; 265(1):23-30. PubMed ID: 20663492
    [Abstract] [Full Text] [Related]

  • 28. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A, Solves P, Mateu E, Sepúlveda P, Carbonell-Uberos F, Miñana MD.
    Stem Cells; 2004 Dec 15; 22(5):725-40. PubMed ID: 15342937
    [Abstract] [Full Text] [Related]

  • 29. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
    Kufner S, Zitzelsberger H, Kroell T, Pelka-Fleischer R, Salem A, de Valle F, Schmid C, Schweiger C, Kolb HJ, Schmetzer HM.
    Scand J Immunol; 2005 Jul 15; 62(1):75-85. PubMed ID: 16091127
    [Abstract] [Full Text] [Related]

  • 30. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY, Zhang LS, Zhang YF, Chai Y, Yi LC, Song FX.
    Ai Zheng; 2005 Apr 15; 24(4):425-31. PubMed ID: 15820064
    [Abstract] [Full Text] [Related]

  • 31. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage.
    Lee JJ, Choi BH, Nam JH, Park MS, Song WH, Yang DH, Kim YK, Cho SH, Chung IJ, Park KS, Lee IK, Kim HJ.
    J Clin Apher; 2004 Apr 15; 19(3):130-6. PubMed ID: 15493054
    [Abstract] [Full Text] [Related]

  • 32. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
    Houtenbos I, Westers TM, Dijkhuis A, de Gruijl TD, Ossenkoppele GJ, van de Loosdrecht AA.
    Clin Cancer Res; 2007 Jan 01; 13(1):307-15. PubMed ID: 17170077
    [Abstract] [Full Text] [Related]

  • 33. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.
    Cancer Res; 2000 Feb 01; 60(3):610-7. PubMed ID: 10676644
    [Abstract] [Full Text] [Related]

  • 34. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A, Van de Velde AL, Nijs G, Braeckman T, Stein B, De Vries JM, Berneman ZN, Van Tendeloo VF.
    Cytotherapy; 2009 Feb 01; 11(5):653-68. PubMed ID: 19530029
    [Abstract] [Full Text] [Related]

  • 35. [Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA].
    Ge W, You SG, Wang YF, Li CH, Liu XF, He XP, Ma S, Qiu L.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug 01; 26(8):461-4. PubMed ID: 16383235
    [Abstract] [Full Text] [Related]

  • 36. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
    Zheng SE, Jin J, Tong XM, Qian WB, Xue YQ.
    Zhonghua Zhong Liu Za Zhi; 2006 Dec 01; 28(12):920-3. PubMed ID: 17533744
    [Abstract] [Full Text] [Related]

  • 37. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner.
    Jaksits S, Kriehuber E, Charbonnier AS, Rappersberger K, Stingl G, Maurer D.
    J Immunol; 1999 Nov 01; 163(9):4869-77. PubMed ID: 10528188
    [Abstract] [Full Text] [Related]

  • 38. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1.
    Roddie PH, Horton Y, Turner ML.
    Leukemia; 2002 Jan 01; 16(1):84-93. PubMed ID: 11840267
    [Abstract] [Full Text] [Related]

  • 39. Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.
    Moldenhauer A, Nociari M, Lam G, Salama A, Rafii S, Moore MA.
    Stem Cells; 2004 Jan 01; 22(2):144-57. PubMed ID: 14990854
    [Abstract] [Full Text] [Related]

  • 40. AML-loaded DC generate Th1-type cellular immune responses in vitro.
    Xing D, Decker WK, Li S, Robinson SN, Yang H, Segal H, O'Connor S, Yao X, Komanduri KV, McMannis JD, Jones RB, de Lima M, Champlin RE, Shpall EJ.
    Cytotherapy; 2006 Jan 01; 8(2):95-104. PubMed ID: 16698683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.